Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Update on sentinel lymph node evaluation in gynecologic malignancies.

Katina Robison1, Laura L Holman, Richard G Moore

  • 1Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Alpert Medical School, Brown University, Providence, Rhode Island, USA.

Current Opinion in Obstetrics & Gynecology
|January 15, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same author

Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9.

bioRxiv : the preprint server for biology·2026
Same author

Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004.

Gynecologic oncology·2026
Same author

Combined Urogynecology and Gynecologic Oncology Surgery Complications.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.

International journal of radiation oncology, biology, physics·2026
Same author

Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Sentinel lymph node (SLN) dissection is a safe and effective method for staging gynecologic cancers, particularly vulvar cancer. Further research is needed for endometrial and cervical cancers to optimize this minimally invasive approach.

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Cancer Staging

Background:

  • Sentinel lymph node (SLN) dissection offers reduced morbidity compared to complete lymph node dissection.
  • SLN technology is gaining traction in gynecologic oncology.
  • This review evaluates the existing literature on SLN dissections in gynecologic malignancies.

Purpose of the Study:

  • To assess the current evidence for SLN dissections in gynecologic cancers.
  • To determine the safety and efficacy of SLN biopsy in various gynecologic malignancies.

Main Methods:

  • Literature review of evidence-based studies.
  • Analysis of data on sensitivity, specificity, and false-negative rates of SLN biopsy.
  • Evaluation of safety and feasibility in early-stage gynecologic cancers.

More Related Videos

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

Related Experiment Videos

Last Updated: Jun 5, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

Main Results:

  • SLN biopsy is safe and feasible for early-stage vulvar cancer with high negative predictive value.
  • For endometrial cancer, SLN biopsy shows low false-negative rates but variable sensitivity and detection rates.
  • Studies in early-stage cervical cancer (1B1) indicate promising detection rates, sensitivity, and low false-negative rates exceeding 90%.

Conclusions:

  • SLN dissection is an effective and safe alternative surgical approach for select vulvar cancer patients.
  • SLN dissection shows encouraging but preliminary results for endometrial and cervical cancers, requiring further investigation.